Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Portal Hypertension and Cirrhosis is Scopus-indexed (Q3, CiteScore 2.3), WoS ESCI, DOAJ. Published by John Wiley and Sons Inc.
Checked against the index lists dated .
ISSN 2770-5838Verify ISSN ↗2770-5846Verify ISSN ↗
Publisher: John Wiley and Sons Inc
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Gastroenterology | 106 / 176 | 40th | Q3 |
| Hepatology | 57 / 88 | 35th | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2022–present, best quartile Q3, CiteScore 2.3.
Portal Hypertension and Cirrhosis is Q3 in Gastroenterology (rank 106 of 176) and Q3 in Hepatology (rank 57 of 88), by CiteScore 2025.
Portal Hypertension and Cirrhosis is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.3, which places it in quartile Q3 at the 40th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.649, quartile Q2, with an H-index of 8.
No article processing charge is recorded for it (source: OpenAlex). Confirm on the journal's own website, since some journals charge for extras such as colour figures.
Portal Hypertension and Cirrhosis is published by John Wiley and Sons Inc. Its print ISSN is 2770-5838 and its online ISSN is 2770-5846.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Portal Hypertension and Cirrhosis has an h-index of 9 and a 2-year mean of 0.77 citations per paper (OpenAlex). Its Scopus CiteScore is 2.3, quartile Q3. On 2-year citations it ranks #115 of 172 Scopus journals in Gastroenterology.
Portal Hypertension and Cirrhosis published 37 papers in 2025; its busiest recent year was 2023 with 39. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 99 research articles (2023–2026), authors are most often from China (83.2%), United States (3.4%) and Japan (2.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.